Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Disease

Heart Disease, Ischemic

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 6, 2026 · PHASE 1 TRIAL

AB-1002 in Patients With Class III Heart Failure

ClinicalTrials.gov

Phase 1 open-label dose escalation study with no results posted; designed to explore safety and feasibility in a small uncontrolled cohort.

PreliminaryHeart Disease, Ischemic Heart Failure NCT04179643

Reported

Planned enrollment11

Study phasePHASE 1

Primary outcome: Peak VO2Measured at screening, month 6, 9 and month…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support